期刊文献+

心房颤动抗栓治疗的博弈 被引量:5

下载PDF
导出
摘要 1 抗栓治疗策略的变化 1.1 抗栓治疗地位的变化心房颤动(房颤)是常见的心律失常.随病情进展,发作频率的增加,持续时间延长,缺血性卒中和全身血栓事件可显著增加,房颤患者发生脑卒中的风险是窦性心律人群的5~6倍,其导致的卒中占全部卒中的15%左右[1],房颤主要的治疗目标是减少住院、死亡与卒中.因此,房颤治疗的三大原则重点也随之发生着改变,由最初的首先节律控制、其后心室率控制、最后抗栓治疗,发展到律、率控制齐头并进至今日抗栓治疗跃居第一位的策略.
出处 《中国循证心血管医学杂志》 2012年第3期180-182,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
  • 相关文献

参考文献17

  • 1Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study[J].Stroke,1991,22(8):983-988.
  • 2Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Eur Heart J,2010,31(19):2369-2429.
  • 3Wyse DG,Waldo AL,DiMarco JP,et al.A comparison of rate control and rhythm control in patients with atrial fibrillation[J].N Engl J Med,2002,347(23):1825-1833.
  • 4Israel CW,Gronefeld G,Ehrlich JR,et al.Long-term risk of recurrent atrail fibrillation as documengted by an implantable monitoring device implications for optimal patient care[J].J Am Coll Cardiol,2004,43(1):47-52.
  • 5Patten M.Asymptomatic atrial fibrillation with systematic screening using tele-ECG--relevance for anticoagulation in paroxysmal atrial fibrillation[J].Herzschrittmacherther Elektrophysiol,2005,16(3):159-164.
  • 6Shin HW,Kim YN,Bae HJ,et al.Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation:The KORean Atrial Fibrillation Investigation[J].Korean Circ J,2012,42(2):113-117.
  • 7ACTIVE Writing Group of the ACTIVE Investigators,Connolly S,Pogue J,et al.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W):a randomised controlled trial[J].Lancet,2006,367(9526):1903-1912.
  • 8Gao Q,Fu X,Wei JW,et al.Use of oral anticoagulation among stroke patients with atrial fibrillation in China:the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study[J].Int J Stroke.2011 Dec 14.[Epub ahead of print].
  • 9Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361(12):1139-1151.
  • 10Patel MR,Mahaffey KW,Garg J,et al.Rivaroxaban versus warfarin in nonvalvular atrial fibrillation[J].N Engl J Med,2011,365(10):883-891.

同被引文献31

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部